REQUEST A DEMO
Total
USD $0.00
Search more companies

Hlb Pharmaceutical Co., Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Hlb Pharmaceutical Co., Ltd. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

C-Tri Co.,Ltd. is engaged in manufacturing and developing pharmaceutical products. The company offers peptides, antiviral drugs, ionic liquids and others. In addition, C-Tri Co.,Ltd. provides OTC and ETC contract services. The company is based in Namyangju, South Korea. C-Tri Co.,Ltd. was incorporated in 1998.

Headquarters
27 Gyeonggang-Ro
Namyangju; Gyeonggi; Postal Code: 12244

Contact Details: Purchase the Hlb Pharmaceutical Co., Ltd. report to view the information.

Website: http://www.c-tri.co.kr

Basic Information
Total Employees:
Purchase the Hlb Pharmaceutical Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Hlb Pharmaceutical Co., Ltd. report to view the information.
Registered Capital:
Purchase the Hlb Pharmaceutical Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Hlb Pharmaceutical Co., Ltd. report to view the information.
Incorporation Date:
April 23, 1998
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
10.5%
Purchase this report to view the information.
3.4%
Purchase this report to view the information.
1.5%
Subsidiaries
(주)신화어드밴스
(주)아이오쏠라
(주)엘에스케이인베스트먼트
Company Performance
Financial values in the chart are available after Hlb Pharmaceutical Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
26.49%
Total operating revenue
43.91%
Operating profit (EBIT)
24.52%
Net Profit (Loss) for the Period
-64.96%
Total assets
-0.58%
Total equity
2.59%
Operating Profit Margin (ROS)
4.3%
Net Profit Margin
-3.33%
Return on Equity (ROE)
-8.33%
Debt to Equity Ratio
-3.75%
Quick Ratio
0.24%
Cash Ratio
-0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?